Docusign (NASDAQ:DOCU) Insider James Shaughnessy Sells 12,000 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) insider James Shaughnessy sold 12,000 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the completion of the sale, the insider owned 52,815 shares in the company, valued at $2,405,195.10. This trade represents a 18.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Performance

Shares of NASDAQ DOCU opened at $46.02 on Thursday. The stock has a market cap of $8.79 billion, a PE ratio of 29.88, a PEG ratio of 1.31 and a beta of 0.90. The business has a fifty day moving average of $46.93 and a two-hundred day moving average of $51.11. Docusign Inc. has a 52-week low of $40.16 and a 52-week high of $86.65.

Docusign (NASDAQ:DOCU) last issued its earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, beating the consensus estimate of $0.99 by $0.10. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The company had revenue of $830.24 million for the quarter, compared to the consensus estimate of $824.71 million. During the same quarter in the previous year, the company earned $0.90 EPS. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. Analysts predict that Docusign Inc. will post 2.03 earnings per share for the current year.

Docusign declared that its board has approved a share buyback plan on Tuesday, March 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 21% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Analysts Set New Price Targets

A number of research firms have recently issued reports on DOCU. UBS Group set a $60.00 target price on shares of Docusign in a research note on Friday, June 5th. BTIG Research decreased their price target on Docusign from $70.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Piper Sandler dropped their price target on Docusign from $75.00 to $52.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. Citigroup lifted their price objective on Docusign from $50.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, June 5th. Finally, Wedbush decreased their target price on Docusign from $60.00 to $58.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $60.27.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
• Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
• Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
• Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
• Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.

Institutional Trading of Docusign

Several hedge funds have recently modified their holdings of DOCU. Central Pacific Bank Trust Division acquired a new stake in shares of Docusign in the fourth quarter valued at approximately $25,000. Modus Advisors LLC bought a new position in Docusign in the 4th quarter worth approximately $27,000. Torren Management LLC acquired a new position in Docusign during the 4th quarter worth $28,000. Aventura Private Wealth LLC acquired a new position in Docusign during the 4th quarter worth $30,000. Finally, True Wealth Design LLC boosted its position in Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after buying an additional 222 shares during the last quarter. 77.64% of the stock is owned by institutional investors.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.